SCK CEN and Quirem Medical announce the first production of Ho-166 microspheres for patient use at the BR2 reactor in Mol, Belgium.
Deventer, June 15, 2021 – A first clinical QuiremSpheres™ patient procedure took place with radioactive holmium-166 microspheres that were activated at the BR2 reactor in